A case of acute coronary syndrome manifesting as an adverse effect of all-trans retinoic acid in a lady with acute promyelocytic leukemia who had no other risk factors for cardiovascular disease [1A]. From: Side Effects of Drugs Annual, 2016 ...
We compared mortality among patients with and without COVID in 2020 using chi-square analysis.Results:Of 166795 admissions for acute leukemia, 71.8% were acute myeloid leukemia (AML), 25.2% were acute lymphoblastic leukemia (ALL) and 3.1% were acute promyelocytic leukemia (APML). Overall, ...
Human acute T leukemia cells (Jurkat) 0.162 Human promyelocytic leukemia cells (HL-60) 0.129 To understand whether perillaldehyde induces a regulated form of cell death and to better understand the stage of cell death, we performed the annexin-V assay. One of the earliest events in most regulat...
The most clinically significant application of ATRA is to treat a rare subtype of an acute myeloid leukemia (AML), called acute promyelocytic leukemia (APL). At the first description this subtype was considered the most difficult to treat [20], while it is now considered as highly curable ...